Infliximab is a monoclonal TNF-α inhibitor that is used in the treatment of several TNF-α-mediated disorders such as rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn’s disease [17–19]. Here, TNF is linked to ulcerative colitis.